CI
BIIB icon

Cambiar Investors’s Biogen BIIB Stock Holding History

Cambiar Investors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-12,500
Closed -$3.54M – 156
2016
Q4 		$3.54M Sell
12,500
-2,500
-17% -$741K 0.06% 118
2016
Q3 		$4.7M Sell
15,000
-5,000
-25% -$1.48M 0.07% 110
2016
Q2 		$4.84M Hold
20,000
– – 0.07% 107
2016
Q1 		$5.21M Hold
20,000
– – 0.07% 101
2015
Q4 		$6.13M Buy
20,000
+10,000
+100% +$2.87M 0.09% 109
2015
Q3 		$2.92M Buy
+10,000
New +$3.3M 0.04% 126

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Cambiar Investors's BIIB Position: Q4 2021 in Review

Cambiar Investors sold out of Biogen (BIIB) in Q4 2021, closing a stake of 185,118 shares — an estimated $52.4M sold.

Cambiar Investors first reported a position in BIIB in Q3 2015 and held it in 25 quarters. The position peaked at $120M in Q4 2015. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q4 2021.

  • Cambiar Investors reported no remaining Biogen position as of Q4 2021 after selling out during the quarter.
  • Cambiar Investors sold 185,118 Biogen shares in Q4 2021, an estimated $52.4M.
  • Cambiar Investors first reported a position in Biogen in Q3 2015 and held it in 25 quarters.
  • Cambiar Investors's Biogen position peaked at $120M in Q4 2015.
  • 1,010 funds tracked by Wall St. Rank held Biogen as of Q4 2021.

Based on Cambiar Investors's 13F filing for Q4 2021, filed 27 Jan 2022.